Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile

Journal of Clinical Microbiology

Volumn 48, Issue 1, 2010, Pages 124-130

  Larson, Ann M ^a,b   Fung, Angela M ^b   Fang, Ferric C ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GLUTAMATE DEHYDROGENASE;

ALGORITHM; ARTICLE; BACTERIAL GENE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOTOXICITY; ENZYME IMMUNOASSAY; FECES ANALYSIS; GOLD STANDARD; NONHUMAN; PERFORMANCE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TCDB BACTERIAL GENE; TISSUE CULTURE;

ADULT; ALGORITHMS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIOLOGICAL TECHNIQUES; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HUMANS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

CLOSTRIDIUM DIFFICILE;

EID: 73949155915     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00734-09     Document Type: Article

References (60)

1. Aichinger, E., C. D. Schleck, W. S. Harmsen, L. M. Nyre, and R. Patel. 2008. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J. Clin. Microbiol. 46:3795-3797.
2. Åkerlund, T., I. Persoon, M. Unemo, T. Norén, B. Svenungsson, M. Wullt, and L. G. Burman. 2008. Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J. Clin. Microbiol. 46:1530-1533.
3. Alcala, L., L. Sánchez-Cambronero, M. P. Catalán, M. Sánchez-Somolinos, M. T. Peláez, M. Marín, and E. Bouza. 2008. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J. Clin. Microbiol. 46:3833-3835.
4. Alfa, M. J., A. Kabani, D. Lyerly, S. Moncrief, L. M. Neville, A. Al-Barrak, G. K. Harding, B. Dyck, K. Olekson, and J. M. Embil. 2000. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 38:2706-2714.
5. Alfa, M. J., B. Swan, B. VanDekerhove, P. Pang, and G. K. Harding. 2002. The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage C. difficile panel, EIA for ToxA/B and cytotoxin assays. Diagn. Microbiol. Infect. Dis. 43:257-263.
6. Anonymous. 2008. CAP Bacteriology Survey Set D-A. Summary. College of American Pathologists, Northfield, IL.
7. Barbut, F., M. Braun, B. Burghoffer, V. Lalande, and C. Eckert. 2009. Rapid diagnosis of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J. Clin. Microbiol. 47:1276-1277.
8. Barbut, F., B. Gariazzo, L. Bonné, V. Lalande, B. Burghoffer, R. Luiuz, and J. Petit. 2007. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect. Control Hosp. Epidemiol. 28:131-139.
9. Barbut, F., V. Lalande, G. Daprey, P. Cohen, N. Marle, B. Burghoffer, and J. C. Petit. 2000. Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated diseases. Eur. J. Clin. Microbiol. Infect. Dis. 19:481-484.
10. Bartlett, J. G. 2002. Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med. 346:334-339.
11. Bartlett, J. G. 2006. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann. Intern. Med. 145:758-764.
12. Belanger, S. D., M. Boissinot, N. Clairoux, F. J. Picard, and M. G. Bergeron. 2003. Rapid detection of Clostridium difficile in feces by real-time PCR. J. Clin. Microbiol. 41:730-734.
13. Borriello, S. P., B. W. Wren, S. Hyde, S. V. Seddon, P. Sibbons, M. M. Krishna, S. Tabaqchali, S. Manek, and A. B. Price. 1992. Molecular, immunological, and biological characterization of a toxin A-negative, toxin Bpositive strain of Clostridium difficile. Infect. Immun. 60:4192-4199.
14. Bouza, E., T. Peláez, R. Alonso, P. Catalán, P. Muñoz, and M. R. Créixems. 2001. 'Second-look' cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J. Hosp. Infect. 48:233-237.
15. Brazier, J. S., S. L. Stubbs, and B. I. Duerden. 1999. Prevalence of toxin A negative/B positive Clostridium difficile strains. J. Hosp. Infect. 42:248-249.
16. Cardona, D. M., and K. H. Rand. 2008. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J. Clin. Microbiol. 46:3686-3689.
17. Cohen, S. H., Y. J. Tang, B. Hansen, and J. J. Silva. 1998. Isolation of a toxin B-deficient mutant strain of Clostridium difficile in a case of recurrent C. difficile-associated diarrhea. Clin. Infect. Dis. 26:410-412.
18. Delmee, M., J. Van Broeck, A. Simon, M. Janssens, and V. Avesani. 2005. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J. Med. Microbiol. 54:187-191.
19. Dubberke, E. R., K. A. Reske, M. A. Olsen, L. C. McDonald, and V. J. Fraser. 2008. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin. Infect. Dis. 46:497-504.
20. Fenner, L., A. F. Widmer, G. Goy, S. Rudin, and R. Frei. 2008. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J. Clin. Microbiol. 46:328-330.
21. Gerding, D. N., S. Johnson, L. R. Peterson, M. E. Mulligan, and J. J. Silva. 1995. Clostridium difficile-associated diarrhea and colitis. Infect. Control. Hosp. Epidemiol. 16:459-477.
22. Gerding, D. N., M. M. Olson, L. R. Peterson, D. G. Teasley, R. L. Gebhard, M. L. Schwartz, and J. T. Lee, Jr. 1986. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch. Intern. Med. 146:95-100.
23. Gilligan, P. H. 2008. Is a two-step glutamate dehydrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile? J. Clin. Microbiol. 46:1523-1525.
24. Guilbault, C., A. C. Labbe, L. Poirier, L. Busque, C. Beliveau, and M. Laverdiere. 2002. Development and evaluation of a PCR method for detection of the Clostridium difficile toxin B gene in stool specimens. J. Clin. Microbiol. 40:2288-2290.
25. Hansen, G., S. Swanzy, R. Gupta, B. Cookson, and A. P. Limaye. 2008. In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing. Eur. J. Clin. Microbiol. Infect. Dis. 27:115-120.
26. Johnson, S., S. P. Sambol, J. S. Brazier, M. Delmée, V. Avesani, M. M. Merrigan, and D. N. Gerding. 2003. International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants. J. Clin. Microbiol. 41:1543-1547.
27. Kato, H., N. Kato, K. Watanabe, K. Watanabe, N. Iwai, H. Nakamura, T. Yamamoto, K. Suzuki, S. M. Kim, Y. Chong, and E. B. Wasito. 1998. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J. Clin. Microbiol. 36:2178-2182.
28. Kelly, C. P., and J. T. LaMont. 2008. Clostridium difficile - more difficult than ever. N. Engl. J. Med. 359:1932-1940.
29. Kelly, C. P., C. Pothoulakis, and J. T. LaMont. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330:257-262.
30. Kim, H., T. V. Riley, M. Kim, C. K. Kim, D. Yong, K. Lee, Y. Chong, and J. Park. 2008. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis. J. Clin. Microbiol. 46:1116-1117.
31. Kyne, L., M. B. Hamel, R. Polavaram, and C. P. Kelly. 2002. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin. Infect. Dis. 34:346-353.
32. Larson, A. M., A. M. Fung, and F. C. Fang. 2006. Direct PCR detection of toxigenic Clostridium difficile from stool specimens, abstr. C-033. Abstr. 106th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
33. Lashner, B. A., J. Todorczuk, D. F. Sahm, and S. B. Hanauer. 1986. Clostridium difficile culture-positive toxin-negative diarrhea. Am. J. Gastroenterol. 81:940-943.
34. Lawrence, S. J., L. A. Puzniak, B. N. Shadel, K. N. Gillespie, M. H. Kollef, and L. M. Mundy. 2007. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect. Control Hosp. Epidemiol. 28:123-130.
35. Lee, S. D., D. K. Turgeon, C. W. Ko, T. R. Fritsche, and C. M. Surawicz. 2003. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease. Am. J. Gastroenterol. 98:1569-1572.
36. Lyerly, D. M., L. A. Barroso, T. D. Wilkins, C. Depitre, and G. Corthier. 1992. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect. Immun. 60:4633-4639.
37. Lyras, D., J. R. O'Connor, P. M. Howarth, S. P. Sambol, G. P. Carter, T. Phumoonna, R. Poon, V. Adams, G. Vedantam, S. Johnson, D. N. Gerding, and J. I. Rood. 2009. Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176-1177.
38. Mathis, J. N., L. Pilkinton, and D. E. McMillin. 1999. Detection and transcription of toxin DNA in a nontoxigenic strain of Clostridium difficile. Curr. Microbiol. 38:324-328.
39. McFarland, L. V., G. W. Elmer, W. E. Stamm, and M. E. Mulligan. 1991. Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients. Infect. Immun. 59:2456-2462.
40. Mohan, S. S., B. P. McDermott, S. Parchuri, and B. A. Cunha. 2006. Lack of value of repeat stool testing for Clostridium difficile toxin. Am. J. Med. 119:356.e7-356.e8.
41. Moncrief, J. S., L. Zheng, L. M. Neville, and D. M. Lyerly. 2000. Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR. J. Clin. Microbiol. 38:3072-3075.
42. O'Brien, J. A., B. J. Lahue, J. J. Caro, and D. M. Davidson. 2007. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect. Control Hosp. Epidemiol. 28:1219-1227.
43. Peterson, L. R., and P. J. Kelly. 1993. The role of the clinical microbiology laboratory in the management of Clostridium difficile-associated diarrhea. Infect. Dis. Clin. North Am. 7:277-293.
44. Peterson, L. R., R. U. Manson, S. M. Paule, D. M. Hacek, A. Robicsek, R. B. Thomson, Jr., and K. L. Kaul. 2007. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin. Infect. Dis. 45:1152-1160.
45. Rakeman, J. L., N. Olson, E. D. Stefansson, T. R. Fritsche, A. P. Limaye, and B. T. Cookson. 2005. A two-step approach to toxigenic Clostridium difficile detection increases diagnostic yield, abstr. C-335. Abstr. 105th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
46. Reller, M. E., C. A. Lema, T. M. Perl, M. Cai, T. L. Ross, K. A. Speck, and K. C. Carroll. 2007. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 45:3601-3605.
47. Reyes, R. C., M. A. John, D. L. Ayotte, A. Covacich, S. Milburn, and Z. Hussain. 2007. Performance of TechLab C. DIFF QUIK CHEK and TechLab. C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples. Diagn. Microbiol. Infect. Dis. 59:33-37.
48. Rupnik, M., N. Kato, M. Grabnar, and H. Kato. 2003. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J. Clin. Microbiol. 41:1118-1125.
49. Samra, Z., S. Talmor, and J. Bahar. 2002. High prevalence of toxin A-negative toxin B-positive Clostridium difficile in hospitalized patients with gastrointestinal disease. Diagn. Microbiol. Infect. Dis. 43:189-192.
50. Sloan, L. M., B. J. Duresko, D. R. Gustafson, and J. E. Rosenblatt. 2008. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J. Clin. Microbiol. 46:1996-2001.
51. Snell, H., M. Ramos, S. Longo, M. John, and Z. Hussain. 2004. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 42:4863-4865.
52. Song, X., J. G. Bartlett, K. Speck, A. Naegeli, K. Carroll, and T. M. Perl. 2008. Rising economic impact of Clostridium difficile-associated disease in adult hospitalized patient population. Infect. Control Hosp. Epidemiol. 29:823-828.
53. Spigaglia, P., and P. Mastrantonio. 2002. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J. Clin. Microbiol. 40:3470-3475.
54. Stamper, P. D., R. Alcabasa, D. Aird, W. Babiker, J. Wehrlin, I. Ikpeama, and K. C. Carroll. 2009. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J. Clin. Microbiol. 47:373-378.
55. Stare, B. G., M. Delmee, and M. Rupnik. 2007. Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strains. J. Med. Microbiol. 56:329-335.
56. Svenungsson, B., L. G. Burman, K. Jalakas-Pörnull, A. Lagergren, J. Struwe, and T. Åkerlund. 2003. Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital. J. Clin. Microbiol. 41:4031-4037.
57. Ticehurst, J. R., D. Z. Aird, L. M. Dam, A. P. Borek, J. T. Hargrove, and K. C. Carroll. 2006. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J. Clin. Microbiol. 44:1145-1149.
58. Turgeon, D. K., T. J. Novicki, J. Quick, L. Carlson, P. Miller, B. Ulness, A. Cent, R. Ashley, A. Larson, M. Coyle, A. P. Limaye, B. T. Cookson, and T. R. Fritsche. 2003. Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J. Clin. Microbiol. 41:667-670.
59. U.S. Department of Labor, Bureau of Labor Statistics. Accessed 21 July 2009. Consumer Price Index. http://www.bls.gov/data/inflation-calculator. htm.
60. van den Berg, R. J., N. Vaessen, H. P. Endtz, T. Schulin, E. R. van der Vorm, and E. J. Kuijper. 2007. Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. J. Med. Microbiol. 56:36-42.